Civic Intelligence

Biopharmaceutical Applied Statistics Symposium Inc.

990EZ • Fiscal year 2013 • EIN 45-5190806

Jan 01, 2013 to Dec 31, 2013

Charlotte, NC
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

45th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2013 filings • NTEE E • <$500k nonprofits • Source year 2013

Liabilities / Revenue

45th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2013 filings • NTEE E • <$500k nonprofits • Source year 2013

Net Margin

91st percentile

57%

Higher net margin than 91% of similar nonprofits.

2013 filings • NTEE E • <$500k nonprofits • Source year 2013

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2013

Asset Growth

79th percentile

27%

Faster asset growth than 79% of similar nonprofits.

2013 filings • NTEE E • <$500k nonprofits • Annualized from 2012 to 2013

Revenue Growth

71st percentile

18%

Faster revenue growth than 71% of similar nonprofits.

2013 filings • NTEE E • <$500k nonprofits • Annualized from 2012 to 2013

Assets

Up

$54,097

Up $11,562 (+27%) from 2012

Net Assets

-

No earlier filing loaded for comparison.

Liabilities

Down

$0

Down $19,986 (-100%) from 2012

Revenue

Up

$55,047

Up $8,437 (+18%) from 2012

Expenses

Down

$23,499

Down $562 (-2.3%) from 2012

Net Income

Up

$31,548

Up $8,999 (+40%) from 2012

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$300K$200K$100K$0Assets 2012: $42,535Liabilities 2012: $19,9862012Assets 2013: $54,097Liabilities 2013: $02013Assets 2014: $105,100Liabilities 2014: $02014Assets 2015: $139,089Liabilities 2015: $02015Assets 2016: $151,100Liabilities 2016: $02016Assets 2017: $166,067Liabilities 2017: $02017Assets 2018: $181,679Liabilities 2018: $02018Assets 2019: $198,204Net Assets 2019: $198,2042019Assets 2020: $207,875Net Assets 2020: $207,8752020Assets 2021: $220,321Liabilities 2021: $545Net Assets 2021: $219,7762021Assets 2022: $239,130Liabilities 2022: $1,063Net Assets 2022: $238,0672022Assets 2023: $240,570Liabilities 2023: $1,212Net Assets 2023: $239,3582023Assets 2024: $250,345Liabilities 2024: $1,288Net Assets 2024: $249,0572024

Highlighted filing

2013

Assets$54,097
Liabilities$0
Net Assets-

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$100K$50K$0Revenue 2012: $46,610Expenses 2012: $24,061Net Income 2012: $22,5492012Revenue 2013: $55,047Expenses 2013: $23,499Net Income 2013: $31,5482013Revenue 2014: $80,671Expenses 2014: $29,668Net Income 2014: $51,0032014Revenue 2015: $56,946Expenses 2015: $22,957Net Income 2015: $33,9892015Revenue 2016: $39,679Expenses 2016: $28,130Net Income 2016: $11,5492016Revenue 2017: $43,762Expenses 2017: $28,795Net Income 2017: $14,9672017Revenue 2018: $48,319Expenses 2018: $32,708Net Income 2018: $15,6112018Revenue 2019: $58,229Expenses 2019: $41,704Net Income 2019: $16,5252019Revenue 2020: $11,161Expenses 2020: $1,490Net Income 2020: $9,6712020Revenue 2021: $13,430Expenses 2021: $1,529Net Income 2021: $11,9012021Revenue 2022: $36,131Expenses 2022: $17,840Net Income 2022: $18,2912022Revenue 2023: $31,474Expenses 2023: $30,183Net Income 2023: $1,2912023Revenue 2024: $36,529Expenses 2024: $26,830Net Income 2024: $9,6992024

Highlighted filing

2013

Revenue$55,047
Expenses$23,499
Net Income$31,548
Filing Detail Status

This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2013 to Dec 31, 2013
Mission and Program Overview

Mission

Educational symposium to raise funds to support graduate students in the field of biostatics.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings